Navigation Links
EvaluatePharma Appoints Alexander Karle as COO
Date:9/12/2012

LONDON and BOSTON, September 12, 2012 /PRNewswire/ --

EvaluatePharma®, the premier source for life science sector analysis and consensus forecasts, has appointed Alexander Karle as Chief Operating Officer. Karle's experience in formulating customer-centric growth strategies and leading them to successful implementation will be instrumental in driving EvaluatePharma's continued expansion within key industry sectors and geographic markets.

Prior to joining EvaluatePharma, Karle served as Vice President of Strategy and Development for global intelligence firm Thomson Reuters. There, he served on the executive leadership team and was responsible for defining and leading the corporate growth strategy for Thomson Reuters' intellectual property and science division, an $800M+ information and services business. Karle also led the restructuring of Thomson Reuters' pharmaceutical benchmarking business, CMR International, where he set strategy and defined new services to integrate with Thomson Reuters' life sciences business. Karle began his professional career as a Senior Associate at Booz Allen & Hamilton. Karle holds a Bachelor of Arts in business, economics and law from the European Business Programme in Münster, Germany and Hull, United Kingdom as well as a Master of Business Administration from Yale University's School of Management.

"Alexander brings a breadth of experience in driving corporate development for global intelligence firms within the life sciences. His expertise in driving successful operational growth for Thomson Reuters' science and healthcare businesses will be incredibly relevant," said Dr. Jonathan de Pass, EvaluatePharma CEO. "We are thrilled to welcome someone of his caliber to our executive leadership team."

About EvaluatePharma

Since 1996, EvaluatePharma has been the premier source for life science sector analysis, delivering exclusive, trusted commercial insight into industry performance through its proprietary platform. EvaluatePharma is staffed by a team of over 85 dedicated healthcare analysts employing rigorous methodologies to deliver the most-up-to-date commercial performance data available. An award winning editorial team of journalists writing under the EP Vantage name support EvaluatePharma's analysis.  The EvaluatePharma services enable the life science community to make sound business decisions about value and opportunity. For more information please visit http://www.EvaluatePharma.com.

Media Contacts:
EvaluatePharma
Christine Lindgren
+1-617-866-3906
christinel@EvaluatePharma.com

Chempetitive Group
Erik Clausen
+1-858-457-2436
rlear@chempetitive.com


'/>"/>
SOURCE EvaluatePharma Ltd
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. EvaluatePharma Names Debbie Paul CEO, Americas to Lead Growth in Key Region
2. AMRI Appoints Michael Nolan Vice President, Chief Financial Officer and Treasurer
3. Insmed Appoints Will Lewis as President and Chief Executive Officer
4. Circassia Appoints Dr Brett Haumann as Chief Medical Officer
5. Kinex Pharmaceuticals Appoints Mr. Patrick Gallagher Vice President of Business Development and Investor Relations
6. Islet Sciences Appoints Dr. Kevan Herold and Dr. Morton Printz to Scientific Advisory Board
7. Ameritox Appoints New CEO, Scott Walton
8. Cell Therapeutics, Inc. (CTI) Appoints Former Managing Director, Head of West Coast Biotechnology for Oppenheimer/CIBC Matthew J. Plunkett Executive Vice President, Corporate Development
9. IRIDEX Appoints Chairman William M. Moore as Interim President & CEO
10. Landauer, Inc. Appoints Ronald Zilkowski To Vice President, Corporate Controller And Chief Accounting Officer
11. Henry Schein Appoints Carol Raphael to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... 12, 2017 AVACEN Medical , Inc. (AVACEN) ... their  2017 New Product Innovation Award for Its fibromyalgia ... and secondary medical device market research by Frost & Sullivan,s ... OTC, drug-free pain relief product, the AVACEN 100, offers a ... fibromyalgia widespread pain. ...
(Date:10/11/2017)... 2017  True Health, a leader in integrated ... during National Breast Cancer Awareness month to educate ... Research recently published ... more than 10 million American women are at ... or BRCA2 and have not had testing. These mutations ...
(Date:10/5/2017)...  In response to the nationwide opioid epidemic, ... (AAOMS) released prescribing recommendations that urge ibuprofen – ... a first-line therapy to manage a patient,s acute ... Recognizing the value and importance of the ... Acute and Postoperative Pain Management" stresses that practitioners ...
Breaking Medicine Technology:
(Date:10/13/2017)... Calif. (PRWEB) , ... October 13, 2017 , ... Many ... dementia. However, many long-term care insurance companies have a waiver for care if the ... 90-day elimination period, when the family pays for care, is often waived, so the ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented host, actor Rob ... sciatica in a new episode of "Success Files," which is an award-winning educational ... and investigates each subject in-depth with passion and integrity. , Sciatica occurs when ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San Francisco ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are estimated ... in breathing. Oral appliances can offer significant relief to about 75 percent of ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a nationally ... care, have expanded their existing home health joint venture through an agreement, effective ... operating a joint venture home health company with Asante, delivering clinically integrated care, ...
(Date:10/12/2017)... , ... October 12, 2017 , ... On Saturday, October ... treadmill relay – Miles by Moonlight to raise money for the American Heart Association ... more. , Teams will work together to keep their treadmills moving for 5 ...
Breaking Medicine News(10 mins):